Back Home Search

Urothelial/Bladder

    • Protocols

    • A032103

      OPEN TO ACCRUAL

      Ph 2/3 Nivo +/- Relatlimab in adjuvant urothelial cancer

    • INT22-09-01

      OPEN TO ACCRUAL

      A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer